Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes

Published:1993-05-01 Issue:5 Volume:42 Page:696-705
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

Kuzuya H.,Matsuura N.,Sakamoto M.,Makino H.,Sakamoto Y.,Kadowaki T.,Suzuki Y.,Kobayashi M.,Akazawa Y.,Nomura M.,et al.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multicenter, open‐label, single‐arm trial of the long‐term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE‐02);Journal of Diabetes Investigation;2024-05-04

2. A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01);Diabetes Therapy;2024-01-13

3. Frequency and characteristics of diabetes in lipodystrophies and insulin receptoropathies compared with type 1 and type 2: results from the multicenter DPV registry;Endocrine Connections;2023-01-17

4. Donohue syndrome in an Egyptian infant: a case report;Case Reports in Perinatal Medicine;2022-12-28

5. Donohue syndrome and use of continuous subcutaneous IGF1 pump therapy;Problems of Endocrinology;2022-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP